Silence Therapeutics Plc Current Assets

Silence Therapeutics Plc (SLN) currently reports a current assets of $94M as of June 2026. That compares with $150M in the prior-year period — down 36.5% year over year. Use the charts on this page to explore Silence Therapeutics Plc's current assets history and peer comparisons.

Silence Therapeutics Plc's current assets decreased from $150M to $94M — a 36.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Silence Therapeutics Plc reported $94M in current assets as of June 2026. That compares with $150M in the prior-year period — down 36.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $94M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Silence Therapeutics Plc, and consider following SLN for alerts when major investors trade the stock.

Silence Therapeutics Plc is classified in the Healthcare sector. On current assets, it currently shows $94M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SLN with unrelated industries.